Black Rock Inc. Vertex Pharmaceuticals Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Black Rock Inc. holds 21,312,244 shares of VRTX stock, worth $9.61 Billion. This represents 0.23% of its overall portfolio holdings.

Number of Shares

21,312,244

Previous 21,960,687 2.95%

Holding current value

$9.61 Billion

Previous $9.18 Billion 8.82%

% of portfolio

0.23%

Previous 0.22%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $255 Million - $315 Million	-648,443 Reduced 2.95%	21,312,244 $9.99 Billion
Q1 2024 May 10, 2024	BUY	$407.69 - $446.08 $32.4 Million - $35.5 Million	79,484 Added 0.36%	21,960,687 $9.18 Billion
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $241 Million - $289 Million	-704,023 Reduced 3.12%	21,881,203 $8.9 Billion
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $79.5 Million - $85.3 Million	-235,200 Reduced 1.03%	22,585,226 $7.85 Billion
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $342 Million - $382 Million	-1,086,177 Reduced 4.54%	22,820,426 $8.03 Billion
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $94.8 Million - $108 Million	-334,834 Reduced 1.38%	23,906,603 $7.53 Billion
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $286 Million - $322 Million	-1,001,623 Reduced 3.97%	24,241,437 $7 Billion
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $29 Million - $32.4 Million	105,908 Added 0.42%	25,243,060 $7.31 Billion
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $287 Million - $357 Million	1,220,898 Added 5.1%	25,137,152 $7.08 Billion
Q1 2022 May 12, 2022	SELL	$221.42 - $260.97 $6.35 Million - $7.48 Million	-28,677 Reduced 0.12%	23,916,254 $6.24 Billion
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $70.3 Million - $88.7 Million	397,036 Added 1.69%	23,944,931 $5.26 Billion
Q3 2021 Nov 09, 2021	BUY	$181.39 - $202.99 $34.1 Million - $38.1 Million	187,806 Added 0.8%	23,547,895 $4.27 Billion
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $4.38 Billion - $5.16 Billion	23,360,089 New	23,360,089 $4.71 Billion

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account